to experience the full functionality of mail.com.
Enhanced by Google
July 12, 2016
Lower-cost biotech drug gets thumbs up from FDA panel
The second-biggest selling drug in the world could get some cheaper competition in the U.S., after a federal panel endorsed ...
April 13, 2016
Napster co-founder bankrolls project to speed cancer work
A project to speed development of cancer-fighting drugs that harness the immune system has academic and drug industry ...
April 05, 2016
FDA approves 1st cheaper version of J&J's top drug Remicade
Federal health officials have approved a cheaper version of Johnson & Johnson's blockbuster drug, Remicade, a pricey biotech ...
March 01, 2016
Study: $3B will be wasted on unused portion of cancer drugs
High prices for cancer medicines aren't the only reason they cost insurers and patients so much. Waste pads the bill, a study ...